Short interest in bluebird bio Inc (NASDAQ:BLUE) decreased during the last reporting period, falling from 49.42M to 47.71M. This put 26.66% of the company's publicly available shares short.

Please check the store stock via "Find in Store".

Bluebird has just two quarters until it’s out of cash ... “We still question the company’s ability to translate this into patient starts and revenue, particularly given it appears the company will ...

Sure, a dog's neck is not as impressive as the neck of a giraffe, but it carries many roles. Discover five fascinating facts about a dog's neck. A dog's neck main function is to support the dog's head ...

The early pterosaurs had short heads on short necks, a short bone in the wrist of the wing, a long 5th toe on the foot and long tails, and the pterodactyloids had the opposite: large heads on long ...

In the closing of the recent trading day, Blue Bird (BLBD) stood at $37.66, denoting a +0.21% change from the preceding trading day. MACON, Ga., November 13, 2024--Blue Bird Corporation (Nasdaq ...

Reviewers say they actually catch (human and pet) hair too! Promising review: "These cute little waving saguaro cactus dryer ...

Bluebird Bio's Q3 EPS loss was 31 cents, beating consensus estimates of a 36-cent loss. Bluebird Bio's cash balance is $118.7 million, providing a runway into Q1 2025. The gene therapy company ...